Effectiveness of oral tipepidine administration for children with attention deficit/hyperactivity disorder: A 4-week, open-label clinical study.
Research Center for Child Mental Development, University of Fukui, Fukui, Japan.|Department of Child and Adolescent Psychological Medicine, University of Fukui Hospital, Fukui, Japan.
Akemi
A
Tomoda
Research Center for Child Mental Development, University of Fukui, Fukui, Japan.|Department of Child and Adolescent Psychological Medicine, University of Fukui Hospital, Fukui, Japan.
Shinichiro
S
Takiguchi
Research Center for Child Mental Development, University of Fukui, Fukui, Japan.
Takashi X
TX
Fujisawa
Research Center for Child Mental Development, University of Fukui, Fukui, Japan.|Department of Child and Adolescent Psychological Medicine, University of Fukui Hospital, Fukui, Japan.
Chiho
C
Yatsuga
Research Center for Child Mental Development, University of Fukui, Fukui, Japan.|Department of Child and Adolescent Psychological Medicine, University of Fukui Hospital, Fukui, Japan.
Hirokazu
H
Kumazaki
Research Center for Child Mental Development, University of Fukui, Fukui, Japan.|Department of Child and Adolescent Psychological Medicine, University of Fukui Hospital, Fukui, Japan.
Toru
T
Fujioka
Department of Child and Adolescent Psychological Medicine, University of Fukui Hospital, Fukui, Japan.
Hitomi
H
Suzuki
Research Center for Child Mental Development, University of Fukui, Fukui, Japan.|Department of Child and Adolescent Psychological Medicine, University of Fukui Hospital, Fukui, Japan.
Hideo
H
Matsuzaki
Research Center for Child Mental Development, University of Fukui, Fukui, Japan.|Department of Child and Adolescent Psychological Medicine, University of Fukui Hospital, Fukui, Japan.
Hirotaka
H
Kosaka
Research Center for Child Mental Development, University of Fukui, Fukui, Japan.
Shiho
S
Tanaka
D000284:Administration, Oral; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D005500:Follow-Up Studies; D006801:Humans; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D016896:Treatment Outcome
D010880:Piperidines; C028458:tipepidine